TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 NOK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
389
|
482
|
378 |
| Financial expenses |
3
|
5
|
0 |
| Earnings before taxes |
104
|
226
|
21 |
| EBITDA |
-56
|
62
|
-35 |
| Total assets |
7,470
|
7,098
|
6,742 |
| Current assets |
7,032
|
6,681
|
6,325 |
| Current liabilities |
100
|
167
|
85 |
| Equity capital |
7,327
|
6,848
|
6,586 |
| - share capital |
106
|
100
|
99 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
98.1%
|
96.5%
|
97.7% |
| Turnover per employee |
389
|
482
|
378 |
| Profit as a percentage of turnover |
26.7%
|
46.9%
|
5.6% |
| Return on assets (ROA) |
1.4%
|
3.3%
|
0.3% |
| Current ratio |
7032.0%
|
4000.6%
|
7441.2% |
| Return on equity (ROE) |
1.4%
|
3.3%
|
0.3% |
| Change turnover |
-121
|
98
|
138 |
| Change turnover % |
-24%
|
26%
|
57% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.